SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,246
Boards Moderated 0
Alias Born 02/13/10
160x600 placeholder
Navidea to Host Moderated Q&A Webcast with Management Business Wire - 2/1/2018 5:25:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/28/2017 6:02:57 AM
Navidea Biopharmaceuticals to Present at Biotech Showcase 2018 Business Wire - 12/19/2017 4:05:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 12/15/2017 4:21:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2017 4:20:38 PM
Navidea Biopharmaceuticals to Present at LD Micro 10th Annual Main Event Business Wire - 11/21/2017 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2017 4:12:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2017 6:08:07 AM
Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results Business Wire - 11/7/2017 4:30:00 PM
Navidea to Present Late-Breaking Abstract at American College of Rheumatology Annual Meeting Business Wire - 11/1/2017 9:00:00 AM
Navidea Biopharmaceuticals Schedules Third Quarter 2017 Earnings Conference Call and Business Update Business Wire - 10/31/2017 5:53:00 PM
Navidea Signs Letter of Intent to Sublicense NAV4694 Worldwide Development Rights Business Wire - 10/27/2017 8:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2017 4:02:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/19/2017 5:52:39 PM
Navidea Biopharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment Conference Business Wire - 9/8/2017 10:00:00 AM
Navidea To Initiate Regular Webcast Series Featuring Moderated Q&A with Management Business Wire - 8/30/2017 5:18:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2017 3:50:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2017 6:08:43 AM
Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results Business Wire - 8/8/2017 8:41:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2017 4:18:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2017 4:36:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2017 4:36:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2017 4:35:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2017 4:35:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/30/2017 11:19:52 AM
casperboo   Saturday, 05/18/13 11:44:14 PM
Re: KnightlyCruiser post# 3713
Post # of 9004 
$120 per share for NAVB? Let the good Lord hear ya!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist